Yutaka Niihara, M.D., MPH, has been reapppointed CEO of Emmaus Life Sciences Inc. Dr. Niihara is co-founder and chairman of the company. Emmaus Life Sciences is engaged in the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases.
On January 15, the Government of India launched a nationwide mobile health program designed to train community health workers and to directly reach millions of women within three years. The […]
New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s […]
Klick attracts leading healthcare marketing professionals with its consistent growth, unique industry approach, and commitment to the ‘relentless pursuit of awesome’ February 04, 2016 11:34 AM Eastern Standard Time TORONTO–(BUSINESS […]
Calcium USA announced that CEO Steven Michaelson (former founder of Wishbone) and Chief Strategy Officer Judy Capano (former Wishbone partner/owner) finalized the purchase of the agency and its assets in […]
Laurie Bartolomeo, John Kemble, Drew Desjardins, and Dan Zaksas, PhD were recognized for outstanding work with clients and leading their respective departments.
Creative veteran brings award-winning pharmaceutical experiences to growing independent agency (Austin, TX) – HCB Health, one of the nation’s top independent healthcare advertising agencies, today named Amy Hansen as senior […]
Lauren Lewis Becomes Managing Director and Nicholas Megjugorac, PhD Moves to Head of Strategy New York (February 4, 2016) — McCann Health North America today announced that Mark Willmann, currently Executive […]
– Takeda obtains rights to Mersana’s XMT-1522 outside U.S. and Canada – – Takeda to create additional Fleximer ADCs; Mersana to have a co-development option – – Mersana to receive […]
LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer Bringing the Total Raised for the Current Class of 4Catalyzer Companies to a Quarter-Billion […]
